| Scrip Code | 540701 |
|---|---|
| NSE Symbol | DCAL |
| MSEI Symbol | NA |
| ISIN | INE385W01011 |
| Name of company | Dishman Carbogen Amcis Limited |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2026 |
| Date of end of financial year | 31-03-2027 |
| Date of board meeting when results were approved | 13-11-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 04-11-2026 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Second quarter |
| Nature of report standalone or consolidated | Consolidated |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Unaudited |
| Segment Reporting | Single segment |
| Description of single segment | Contract Development and Manufacturing Organisation (CDMO), quats, specialty chemicals, Vitamins D3 and its analogues, cholesterols, disinfectants etc. |
| Start date and time of board meeting | 13-11-2026 16:00:00 |
| End date and time of board meeting | 13-11-2026 20:45:00 |
| Whether cash flow statement is applicable on company | Yes |
| Type of cash flow statement | Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification | Not applicable |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-07-2026 | 01-04-2026 |
| B | Date of end of reporting period | 30-09-2026 | 30-09-2026 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| 1 | Income | ||
| Revenue from operations | 50,737.00 | 1,18,501.00 | |
| Other income | 356.00 | 2,172.00 | |
| Total income | 51,093.00 | 1,20,673.00 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 3,097.00 | 17,563.00 |
| (b) | Purchases of stock-in-trade | 0.00 | 0.00 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | 381.00 | (2,662.00) |
| (d) | Employee benefit expense | 32,162.00 | 71,072.00 |
| (e) | Finance costs | 4,010.00 | 7,719.00 |
| (f) | Depreciation, depletion and amortisation expense | 9,042.00 | 18,110.00 |
| (f) | Other Expenses | ||
| 1 | Other Expenditure | 10,501.00 | 21,924.00 |
| Total other expenses | 10,501.00 | 21,924.00 | |
| Total expenses | 59,193.00 | 1,33,726.00 | |
| 3 | Total profit before exceptional items and tax | (8,100.00) | (13,053.00) |
| 4 | Exceptional items | 0.00 | (169.00) |
| 5 | Total profit before tax | (8,100.00) | (13,222.00) |
| 6 | Tax expense | ||
| 7 | Current tax | 35.00 | 368.00 |
| 8 | Deferred tax | (1,462.00) | (1,129.00) |
| 9 | Total tax expenses | (1,427.00) | (761.00) |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | (6,673.00) | (12,461.00) |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 14 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0.00 | 0.00 |
| 16 | Total profit (loss) for period | (6,673.00) | (12,461.00) |
| 17 | Other comprehensive income net of taxes | 9,954.00 | 11,880.00 |
| 18 | Total Comprehensive Income for the period | 3,281.00 | (581.00) |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | (6,673.00) | (12,461.00) | |
| Total profit or loss, attributable to non-controlling interests | 0.00 | 0.00 | |
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | 9,954.00 | 11,880.00 | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | 3,281.00 | (581.00) | |
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 3,136.00 | 3,136.00 | |
| Face value of equity share capital | 2 | 2 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | ||
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | -4.26 | -7.95 | |
| Diluted earnings (loss) per share from continuing operations | -4.26 | -7.95 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | -4.26 | -7.95 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | -4.26 | -7.95 | |
| 24 | Debt equity ratio | 0.4700 | 0.4700 |
| 25 | Debt service coverage ratio | 0.8300 | 0.8300 |
| 26 | Interest service coverage ratio | 2.6100 | 2.6100 |
| 27 | Disclosure of notes on financial results | Textual Information(1) | |
| Textual Information(1) | Notes: 1. The Financial results (standalone and consolidated) have been reviewed by the Audit Committee and approved by the Board of Directors at their meetings held on 13th November, 2026. 2. These financial results (standalone and consolidated) have been prepared in compliance with Ind AS, as notified by the Ministry of Corporate Affairs and prescribed under Section 133 of the Companies Act, 2013, read with relevant rules issued thereunder and other accounting pronouncements generally accepted in India, to the extent applicable. 3. Statutory Auditors have carried out limited review of standalone as well as consolidated financial results of the Company for the quarter and half year ended 30th September, 2026. 4. The excess amount of consideration payable over net assets acquired had been recorded as goodwill amounting to INR 1,326.86 crores in the amalgamation held between Dishman Pharmaceuticals and Chemical Limited and Dishman Care Limited into Dishman Carbogen Amcis Limited accounted in the year 2016-17 as per the Scheme of Amalgamation approved by the Hon’ble High Court, Gujarat, which is different from Ind AS 103 “Business Combinations”. The same was represented by underlying intangible assets acquired on amalgamation and was being amortized over the period of 15 years from the Appointed Date i.e. 1st January, 2015. The value of the Goodwill had already been reduced by Rs. 641.28 crores by March 31, 2022, the Board re-assessed the life of the Goodwill looking at the expected growth and benefits available to the Company. Taking a conservative view, considering the possible impact of COVID and the delay in clearance of EDQM observations for the Bavla site, the Board revised the useful life of goodwill to 15 years starting from 1st April 2022 instead of the remainder useful life of 7 years, with a next time frame to further re-assess the same after COVID and major regulatory clearance. After successfully completing all major regulatory audit in last six to twelve months and the impact of COVID having phased out, the Board now expects the performance of the India business to improve and the current value of Goodwill as on 1st April, 2024 of INR 594.17 Crores as reflecting a fair value of the intangible assets for a sustainably long period. The robust outlook in the CDMO sector also supports the company’s path for growth. Considering all above factors, Board has decided to keep the current goodwill value of INR 594.17 Crores till perpetuity i.e. 99 years considering life with effect from 1st January, 2015. This change in estimate of life will be applicable prospectively over the remaining useful life starting from 1st April, 2024. The goodwill will tested for impairment at the end of every financial year. Had the goodwill not been amortized as required under Ind AS 103, the Depreciation and Amortization expense for the quarter ended 30th September, 2026, 30th June, 2026, 30th September, 2025, for the half year ended 30th September, 2026, half year ended 30th September, 2025 and for the year ended 31st March, 2026 would have been lower by INR 1.66 crores, INR 1.65 crores, INR 1.66 crores, INR 3.31 crores, INR 3.31 crores and INR 6.60 crores respectively, and the Profit Before Tax for the corresponding periods would have been higher by an equivalent amount. 5. The financial results are available for perusal on the Company’s website: www.imdcal.com as well as on the Stock Exchange’s websites i.e. on www.bseindia.com and www.nseindia.com. 6. Group is required to disclose segment information based on the ‘management approach’ as defined in Ind AS 108-Operating Segments, which is how the Chief Operating Decision Maker (CODM) evaluates the Group’s performance and allocates resources based on the analysis of the various performance indicators. CODM reviews the results of the Group engaged in the business of Contract Development and Manufacturing Organisation (CDMO), quats, specialty chemicals, Vitamins D3 and its analogues, cholesterols, disinfectants etc. Accordingly, Group as a whole is a single segment. The information as required under Ind AS 108 is available directly from the financial statements, hence no separate disclosure has been made. 7. Consolidated financial results comprise the results of the parent Company, Dishman Carbogen Amcis Limited and its subsidiaries (together referred as “the Group”) viz. Dishman CARBOGEN AMCIS (Europe) Ltd., Dishman USA Inc., Dishman International Trading (Shanghai) Co. Ltd, CARBOGEN AMCIS Holdings AG., Switzerland; CARBOGEN AMCIS (Shanghai) Co. Ltd.,; CARBOGEN AMCIS BV, Carbogen Amcis Ltd., U.K., CARBOGEN AMCIS AG (“CGAM AG”), Switzerland, CARBOGEN AMCIS SAS, Dishman Carbogen Amcis (Japan) Ltd., Dishman Carbogen Amcis (Singapore) Pte. Ltd.,; Dishman Biotech Ltd.; CARBOGEN AMICS Innovations AG.; DISHMAN CARBOGEN AMCIS AG.; CARBOGEN AMCIS Real Estate, Dishman Medicare Limited (formerly known as Visible Investment Limited) and Dishman Carbogen AMCIS Technology AG. 8. Exceptional items for previous the quarter and half year include a charge of Rs.1.69 crores representing transaction costs for a proposed QIP of equity shares. While these expenses were incurred in the previous financial year, they have been written off during the current quarter following management's decision to abandon the issue due to adverse market conditions and an altered fundraising plan. As these costs are material, non-operating, and do not relate to normal current-period operations, they are presented separately. 9. (a) the Company has duly paid the full principal along with interest payment of senior, secured, rated, listed, taxable, redeemable, transferable, non-convertible debentures of INR 49.99 crores (Indian Rupees Forty Nine Crore and Ninety Nine Lakh only) having ISIN INE385W07034, during the period from 13th July, 2026 to 15th July, 2026 for which due date was 17th July, 2026. (b) the Company had issued Rated, Listed, Senior, Secured, Redeemable, Taxable Non-Convertible Debentures of INR 50.00 crores (Indian Rupees Fifty Crores only) having ISIN INE385W07042 and has maintained 100% security cover of the principal and interest amount as on 30th September, 2026 by creating first ranking exclusive charge on identified land parcel being Freehold Non Agricultural land belonging to the Dishman Infrastructure Limited. Quarterly interest payment due on 26th September, 2026 has been paid during 22nd September, 2026 to 25th September, 2026 and there was no principal payment falling due during the quarter ended 30th September, 2026. (c) the Company had issued Senior, Secured, Rated, Listed, Taxable, Redeemable, Transferable, Non-Convertible Debentures of INR 50.00 crores (Indian Rupees Fifty Crores only) having ISIN INE385W07059 and has maintained 100% security cover of the principal and interest amount as on 30th September, 2026 by creating charge on (i) identified properties of the Company, (ii) identified properties of the Promoter of the Company viz. Mr. Arpit J. Vyas and (iii) identified land parcel being Freehold Non Agricultural land belonging to the Dishman Infrastructure Limited. Quarterly payment towards interest and partial redemption of Principal amount on face value basis due on 20th July, 2026 has been paid on 17th July, 2026. (d) the Company had issued Senior, Secured, Rated, Listed, Transferable, Redeemable, Taxable Non-Convertible Debentures of INR 18.00 crores (Indian Rupees Eighteen Crores only) having ISIN INE385W07067 and has maintained 100% security cover of the principal and interest amount as on 30th September, 2026 by creating charge on identified properties of the Promoter of the Company viz. Mr. Arpit J. Vyas. Quarterly interest payment due on 9th September, 2026 has been paid on 4th September, 2026 and 7th September, 2026 and there was no principal payment falling due during the quarter ended 30th September, 2026. 10. The Company has issued and allotted 7,500 (Seven Thousand Five Hundred) senior, secured, rated, listed, transferable, redeemable, taxable non-convertible debentures denominated in Indian Rupees (INR), having a face value of INR 1,00,000 (Indian Rupees One Lakh) each and an aggregate nominal value of INR 75.00 crores (Rupees Seventy Five Crores only) on a private placement basis (“Debentures”) on 17th August, 2026 as approved by the Board and has received Listing and trading approval from BSE Limited vide its notice dated 19th August, 2026. There is no deviation in use of proceeds from the objects stated in the Disclosure Document. The Secured Non-convertible Debentures of the Company aggregating INR 75.00 crores (Rupees Seventy Five Crores only) as on 30th September, 2026 are secured by creating charge on identified land parcel being Freehold Non Agricultural land belonging to the Dishman Infrastructure Limited. The asset cover in respect of the Secured Debentures of the Company as on 30th September, 2026 is 100% of the principal and interest amount of the said Secured Non-convertible Debentures. Statement of utilization of issue proceeds: (INR in Crores) (1) Name of the Issuer: Dishman Carbogen Amcis Ltd (2) ISIN: INE385W07075 (3) Mode of Fund Raising (Public issues/ Private placement): Private Placement (4) Type of instrument: Secured Non convertible Debentures (5) Date of raising funds: 17-08-2026 (6) Amount Raised: 75.00 (7) Funds utilized: 75.00 (8) Any deviation (Yes/ No): No (9) If 8 is Yes, then specify the purpose of for which the funds were utilized: NA (10) Remarks, if any: None Statement of deviation/ variation in use of Issue proceeds: Particulars: Remarks 1. Name of listed entity: Dishman Carbogen Amcis Ltd 2. Mode of fund raising: Private Placement 3. Type of instrument: Secured Non-convertible Debentures 4. Date of raising funds: 17-08-2026 5. Amount raised: INR 75.00 Crores 6. Report filed for quarter ended: 30/09/2026 7. Is there a deviation/ variation in use of funds raised?: No 8. Whether any approval is required to vary the objects of the issue stated in the prospectus/ offer document?: No 9. If yes, details of the approval so required?: NA 10. Date of approval: NA 11. Explanation for the deviation/ variation: NA 12. Comments of the audit committee after review: This statement as on September 30, 2026, was placed before the Audit Committee at its meeting held on November 13, 2026. The Committee noted the same. 13. Comments of the auditors, if any: NA 14. Objects for which funds have been raised and where there has been a deviation/ variation, in the following table: a. Original object: The proceeds of the issue has been utilized for the following purposes: 1. Capex Including Maintenance capex in its existing manufacturing units based in Gujarat 2. Working capital requirements of the company; 3. Repayment of existing Financial indebtedness of the company; 4. General corporate purposes; 5. Costs and expenses in relation to the issuance of Debentures There is no deviation / variation, in the utilization. b. Modified object, if any: NA c. Original allocation: NA d. Modified allocation, if any: NA e. Funds utilised: NA f. Amount of deviation/ variation for the quarter according to applicable object (in Rs. crore and in %): NA g. Remarks, if any: NA Deviation could mean: a. Deviation in the objects or purposes for which the funds have been raised. b. Deviation in the amount of funds actually utilized as against what was originally disclosed. 11. The Company has issued and allotted 1,500 (One Thousand Five Hundred) senior, secured, rated, listed, redeemable, transferable, taxable non-convertible debentures denominated in Indian Rupees (INR), having a face value of INR 1,00,000 (Indian Rupees One Lakh) each and an aggregate nominal value of INR 15.00 crores (Rupees Fifteen Crores only) on a private placement basis (“Debentures”) on 28th September, 2026 as approved by the Board and has received Listing and trading approval from BSE Limited vide its notice dated 29h September, 2026. There is no deviation in use of proceeds from the objects stated in the Disclosure Document. The Secured Non-convertible Debentures of the Company aggregating INR 15.00 crores (Rupees Fifteen Crores only) as on 30th September, 2026 are secured by creating charge on identified land parcel being Freehold Non Agricultural land belonging to the Dishman Infrastructure Limited. The asset cover in respect of the Secured Debentures of the Company as on 30th September, 2026 is 100% of the principal and interest amount of the said Secured Non-convertible Debentures. Statement of utilization of issue proceeds: (INR in Crores) (1) Name of the Issuer: Dishman Carbogen Amcis Ltd (2) ISIN: INE385W07083 (3) Mode of Fund Raising (Public issues/ Private placement): Private Placement (4) Type of instrument: Secured Non convertible Debentures (5) Date of raising funds: 28-09-2026 (6) Amount Raised: 15.00 (7) Funds utilized: 15.00 (8) Any deviation (Yes/ No): No (9) If 8 is Yes, then specify the purpose of for which the funds were utilized: NA (10) Remarks, if any: None Statement of deviation/ variation in use of Issue proceeds: Particulars: Remarks 1. Name of listed entity: Dishman Carbogen Amcis Ltd 2. Mode of fund raising: Private Placement 3. Type of instrument: Secured Non-convertible Debentures 4. Date of raising funds: 28-09-2026 5. Amount raised: INR 15.00 Crores 6. Report filed for quarter ended: 30/09/2026 7. Is there a deviation/ variation in use of funds raised?: No 8. Whether any approval is required to vary the objects of the issue stated in the prospectus/ offer document?: No 9. If yes, details of the approval so required?: NA 10. Date of approval: NA 11. Explanation for the deviation/ variation: NA 12. Comments of the audit committee after review: This statement as on September 30, 2026, was placed before the Audit Committee at its meeting held on November 13, 2026. The Committee noted the same. 13. Comments of the auditors, if any: NA 14. Objects for which funds have been raised and where there has been a deviation/ variation, in the following table: a. Original object: The proceeds of the issue has been utilized for the following purposes: 1. Capital Expenditure Including Maintenance capital expenditure and reimbursement of capital expenditure incurred. 2. Working capital requirements of the company; 3. Repayment of existing Financial indebtedness of the company; 4. General corporate purposes; 5. Costs and expenses in relation to the issuance of Debentures There is no deviation / variation, in the utilization. b. Modified object, if any: NA c. Original allocation: NA d. Modified allocation, if any: NA e. Funds utilised: NA f. Amount of deviation/ variation for the quarter according to applicable object (in Rs. crore and in %): NA g. Remarks, if any: NA Deviation could mean: a. Deviation in the objects or purposes for which the funds have been raised. b. Deviation in the amount of funds actually utilized as against what was originally disclosed. 12. The company has decided to exercise the option available under Section 200 of the Income Tax Act, 2025, and accordingly, the provisions of the said section shall be applicable to the company with effect from FY 2026–27 onwards. Hence, effective tax rate has changed. 13. The previous quarter / year figures have been re-grouped, re-cast and re-arranged wherever considered necessary to make it comparable. On behalf of the Board of Directors Arpit Vyas Place: Vitznau Global Managing Director Date: 13th November, 2026 DIN - 01540057 |
|---|
| Debt equity ratio | |
|---|---|
| Debt service coverage ratio | |
| Interest service coverage ratio |
| Particulars | Year ended (dd-mm-yyyy) | |
|---|---|---|
| Date of start of reporting period | 01-04-2026 | |
| Date of end of reporting period | 30-09-2026 | |
| Whether results are audited or unaudited | Unaudited | |
| Nature of report standalone or consolidated | Consolidated | |
| Assets | ||
| 1 | Non-current assets | |
| Property, plant and equipment | 2,80,989.00 | |
| Capital work-in-progress | 29,193.00 | |
| Investment property | 434.00 | |
| Goodwill | 4,68,079.00 | |
| Other intangible assets | 8,765.00 | |
| Intangible assets under development | 32,370.00 | |
| Biological assets other than bearer plants | 0.00 | |
| Investments accounted for using equity method | 0.00 | |
| Non-current financial assets | ||
| Non-current investments | 7,528.00 | |
| Trade receivables, non-current | 0.00 | |
| Loans, non-current | 192.00 | |
| Other non-current financial assets | ||
| 1 | Other non-current financial assets | 1,831.00 |
| 2 | Non-current tax Assets | 9,666.00 |
| Total of other non-current financial assets | 11,497.00 | |
| Total non-current financial assets | 19,217.00 | |
| Deferred tax assets (net) | 7,772.00 | |
| Other non-current assets | ||
| 1 | Other non-current assets | 12,703.00 |
| 2 | Right of use assets | 18,707.00 |
| Total of other non-current assets | 31,410.00 | |
| Total non-current assets | 8,78,229.00 | |
| 2 | Current assets | |
| Inventories | 1,11,276.00 | |
| Current financial asset | ||
| Current investments | 1,662.00 | |
| Trade receivables, current | 47,039.00 | |
| Cash and cash equivalents | 1,00,909.00 | |
| Bank balance other than cash and cash equivalents | 19,618.00 | |
| Loans, current | 334.00 | |
| Other current financial assets | ||
| Total of other current financial assets | 4,933.00 | |
| Total current financial assets | 1,74,495.00 | |
| Current tax assets (net) | 0.00 | |
| Other current assets | ||
| 1 | Other current assets | 15,610.00 |
| Total of other current assets | 15,610.00 | |
| Total current assets | 3,01,381.00 | |
| 3 | Non-current assets classified as held for sale | 0.00 |
| 4 | Regulatory deferral account debit balances and related deferred tax Assets | 0.00 |
| Total assets | 11,79,610.00 | |
| Equity and liabilities | ||
| 1 | Equity | |
| Equity attributable to owners of parent | ||
| Equity share capital | 3,136.00 | |
| Other equity | 6,63,971.00 | |
| Total equity attributable to owners of parent | 6,67,107.00 | |
| Non controlling interest | 0.00 | |
| Total equity | 6,67,107.00 | |
| 2 | Liabilities | |
| Non-current liabilities | ||
| Non-current financial liabilities | ||
| Borrowings, non-current | 1,53,175.00 | |
| Trade payables, non-current | ||
| (A) Total outstanding dues of micro enterprises and small enterprises | 0.00 | |
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 0.00 | |
| Total Trade payable | 0.00 | |
| Other non-current financial liabilities | ||
| 1 | Lease liabilities | 17,980.00 |
| 2 | Other financial liabilities | 2,298.00 |
| Total of other non-current financial liabilities | 20,278.00 | |
| Total non-current financial liabilities | 1,73,453.00 | |
| Provisions, non-current | 22,873.00 | |
| Deferred tax liabilities (net) | 2,482.00 | |
| Deferred government grants, Non-current | 0.00 | |
| Other non-current liabilities | ||
| 1 | Other non-current liabilities | 41,589.00 |
| Total of other non-current liabilities | 41,589.00 | |
| Total non-current liabilities | 2,40,397.00 | |
| Current liabilities | ||
| Current financial liabilities | ||
| Borrowings, current | 1,63,194.00 | |
| Trade payables, current | ||
| (A) Total outstanding dues of micro enterprises and small enterprises | 852.00 | |
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 26,691.00 | |
| Total Trade payable | 27,543.00 | |
| Other current financial liabilities | ||
| 1 | Other current financial liabilities | 22,233.00 |
| 2 | Lease liabilities | 7,366.00 |
| Total of other current financial liabilities | 29,599.00 | |
| Total current financial liabilities | 2,20,336.00 | |
| Other current liabilities | 45,650.00 | |
| 1 | Other current liabilities | 45,650.00 |
| Total of other current liabilities | 45,650.00 | |
| Provisions, current | 195.00 | |
| Current tax liabilities (Net) | 5,925.00 | |
| Deferred government grants, Current | 0.00 | |
| Total current liabilities | 2,72,106.00 | |
| 3 | Liabilities directly associated with assets in disposal group classified as held for sale | 0.00 |
| 4 | Regulatory deferral account credit balances and related deferred tax liability | 0.00 |
| Total liabilities | 5,12,503.00 | |
| Total equity and liabilites | 11,79,610.00 | |
| Disclosure of notes on assets and liabilities | ||
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-07-2026 | 01-04-2026 | |||||
| Date of end of reporting period | 30-09-2026 | 30-09-2026 | |||||
| Whether results are audited or unaudited | Unaudited | Unaudited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| Total Segment Revenue | |||||||
| Less: Inter segment revenue | |||||||
| Revenue from operations | |||||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| Total Profit before tax | |||||||
| i. Finance cost | |||||||
| ii. Other Unallocable Expenditure net off Unallocable income | |||||||
| Profit before tax | |||||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| Total Segment Asset | |||||||
| Un-allocable Assets | null | null | |||||
| Net Segment Asset | null | null | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| Total Segment Liabilities | |||||||
| Un-allocable Liabilities | null | null | |||||
| Net Segment Liabilities | null | null | |||||
| Disclosure of notes on segments | |||||||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-07-2026 | 01-04-2026 |
| B | Date of end of reporting period | 30-09-2026 | 30-09-2026 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Remeasurement gains/ (Losses) on defined benefit plans | 17,513.00 | 17,517.00 |
| Total Amount of items that will not be reclassified to profit and loss | 17,513.00 | 17,517.00 | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | 1,193.00 | 1,193.00 |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| 1 | Movement in Foreign currency translation reserve | (8,167.00) | (9,200.00) |
| 2 | Foreign exchange fluctuation in respect of cash flow hedge | 2,600.00 | 6,548.00 |
| Total Amount of items that will be reclassified to profit and loss | (5,567.00) | (2,652.00) | |
| 4 | Income tax relating to items that will be reclassified to profit or loss | 799.00 | 1,792.00 |
| 5 | Total Other comprehensive income | 9,954.00 | 11,880.00 |
| Particulars | Year ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|
| A | Date of start of reporting period | 01-04-2026 | ||||
| B | Date of end of reporting period | 30-09-2026 | ||||
| C | Whether results are audited or unaudited | Unaudited | ||||
| D | Nature of report standalone or consolidated | Consolidated | ||||
| Statement of cash flows | ||||||
| Cash flows from used in operating activities | ||||||
| Profit before tax | (13,222.00) | |||||
| Adjustments for reconcile profit (loss) | ||||||
| Adjustments for finance costs | 0.00 | |||||
| Adjustments for decrease (increase) in inventories | (9,365.00) | |||||
| Adjustments for decrease (increase) in trade receivables, current | 23,215.00 | |||||
| Adjustments for decrease (increase) in trade receivables, non-current | 0.00 | |||||
| Adjustments for decrease (increase) in other current assets | (4,653.00) | |||||
| Adjustments for decrease (increase) in other non-current assets | 0.00 | |||||
| Adjustments for other financial assets, non-current | 0.00 | |||||
| Adjustments for other financial assets, current | 0.00 | |||||
| Adjustments for other bank balances | 0.00 | |||||
| Adjustments for increase (decrease) in trade payables, current | (23,682.00) | |||||
| Adjustments for increase (decrease) in trade payables, non-current | 0.00 | |||||
| Adjustments for increase (decrease) in other current liabilities | 0.00 | |||||
| Adjustments for increase (decrease) in other non-current liabilities | 0.00 | |||||
| Adjustments for depreciation and amortisation expense | 18,110.00 | |||||
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0.00 | |||||
| Adjustments for provisions, current | (1.00) | |||||
| Adjustments for provisions, non-current | 0.00 | |||||
| Adjustments for other financial liabilities, current | 0.00 | |||||
| Adjustments for other financial liabilities, non-current | 0.00 | |||||
| Adjustments for unrealised foreign exchange losses gains | (884.00) | |||||
| Adjustments for dividend income | 0.00 | |||||
| Adjustments for interest income | 0.00 | |||||
| Adjustments for share-based payments | 0.00 | |||||
| Adjustments for fair value losses (gains) | 0.00 | |||||
| Adjustments for undistributed profits of associates | 0.00 | |||||
| Other adjustments for which cash effects are investing or financing cash flow | 0.00 | |||||
| Other adjustments to reconcile profit (loss) | 0.00 | |||||
| Other adjustments for non-cash items | 1,434.00 | |||||
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Total adjustments for reconcile profit (loss) | 4,174.00 | |||||
| Net cash flows from (used in) operations | (9,048.00) | |||||
| Dividends received | 0.00 | |||||
| Interest paid | (7,719.00) | |||||
| Interest received | (221.00) | |||||
| Income taxes paid (refund) | (15.00) | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) operating activities | (1,535.00) | |||||
| Cash flows from used in investing activities | ||||||
| Cash flows from losing control of subsidiaries or other businesses | 0.00 | |||||
| Cash flows used in obtaining control of subsidiaries or other businesses | 0.00 | |||||
| Other cash receipts from sales of equity or debt instruments of other entities | 0.00 | |||||
| Other cash payments to acquire equity or debt instruments of other entities | 0.00 | |||||
| Other cash receipts from sales of interests in joint ventures | 0.00 | |||||
| Other cash payments to acquire interests in joint ventures | 0.00 | |||||
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Proceeds from sales of property, plant and equipment | 0.00 | |||||
| Purchase of property, plant and equipment | 9,911.00 | |||||
| Proceeds from sales of investment property | 0.00 | |||||
| Purchase of investment property | 0.00 | |||||
| Proceeds from sales of intangible assets | 0.00 | |||||
| Purchase of intangible assets | 0.00 | |||||
| Proceeds from sales of intangible assets under development | 0.00 | |||||
| Purchase of intangible assets under development | 0.00 | |||||
| Proceeds from sales of goodwill | 0.00 | |||||
| Purchase of goodwill | 0.00 | |||||
| Proceeds from biological assets other than bearer plants | 0.00 | |||||
| Purchase of biological assets other than bearer plants | 0.00 | |||||
| Proceeds from government grants | 0.00 | |||||
| Proceeds from sales of other long-term assets | 0.00 | |||||
| Purchase of other long-term assets | 0.00 | |||||
| Cash advances and loans made to other parties | 0.00 | |||||
| Cash receipts from repayment of advances and loans made to other parties | 0.00 | |||||
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Dividends received | 0.00 | |||||
| Interest received | 320.00 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | 1,504.00 | |||||
| Net cash flows from (used in) investing activities | (8,087.00) | |||||
| Cash flows from used in financing activities | ||||||
| Proceeds from changes in ownership interests in subsidiaries | 0.00 | |||||
| Payments from changes in ownership interests in subsidiaries | 0.00 | |||||
| Proceeds from issuing shares | 0.00 | |||||
| Proceeds from issuing other equity instruments | 0.00 | |||||
| Payments to acquire or redeem entity's shares | 0.00 | |||||
| Payments of other equity instruments | 0.00 | |||||
| Proceeds from exercise of stock options | 0.00 | |||||
| Proceeds from issuing debentures notes bonds etc | 0.00 | |||||
| Proceeds from borrowings | 64,045.00 | |||||
| Repayments of borrowings | 20,161.00 | |||||
| Payments of lease liabilities | 4,707.00 | |||||
| Dividends paid | 0.00 | |||||
| Interest paid | 7,422.00 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) financing activities | 31,755.00 | |||||
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 22,133.00 | |||||
| Effect of exchange rate changes on cash and cash equivalents | ||||||
| Effect of exchange rate changes on cash and cash equivalents | 0.00 | |||||
| Net increase (decrease) in cash and cash equivalents | 22,133.00 | |||||
| Cash and cash equivalents cash flow statement at beginning of period | 78,776.00 | |||||
| Cash and cash equivalents cash flow statement at end of period | 1,00,909.00 | |||||